PAXT: Pulmonary Imaging of Mild Asthma Using 129Xe MRI and Tc-99-Labeled-Carbon-Imaging (Tc99CImaging)

ConditionMild Asthma
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age17-35
SponsorDr. Grace Parraga

About this trial

The goal of this observational study is to better understand how asthma affects the lungs in young adults (ages 17-35) with mild asthma. The main questions it aims to answer are:

* Can advanced imaging detect abnormal airway function in people with mild asthma? * Do changes in ventilation imaging correlate with asthma symptoms or quality of life? Researchers will compare hyperpolarized xenon-129 MRI and Technegas (Tc-99m) imaging to see if these techniques reveal more detailed lung abnormalities than standard lung function tests.

Participants will:

* Complete a single 2-hour visit * Undergo two types of lung imaging: Hyperpolarized xenon-129 MRI (to visualize how air moves in the lungs), Technegas (Tc-99m) imaging (to assess airflow using nuclear medicine) * Perform spirometry and other breathing tests * Answer questionnaires about asthma symptoms and quality of life This study is designed to improve our understanding of subtle changes in lung function that may not be detected by standard tests in people with mild asthma. The findings may lead to better diagnostic tools and more personalized treatment strategies in the future.

Eligibility criteria

Qualifiers

Participant diagnosed with mild (GINA1) asthma by physician

Participant understands study procedures and is willing to participate in the study as indicated by the participant's signature

Provision of written, informed consent prior to any study specific procedures

Males and females 17 to 35 years of age

Disqualifiers

Participant has an implanted mechanically, electrically, or magnetically activated device or any metal in their body which cannot be removed, including but not limited to pacemakers, neurostimulators, biostimulators, implanted insulin pumps, aneurysm clips, bioprosthesis, artificial limb, metallic fragment or foreign body, shunt, surgical staples (including clips or metallic sutures and/or ear implants) (at the discretion of the MRI Technologist)

In the investigator's opinion, subject suffers from any physical, psychological or other condition(s) that might prevent performance of the MRI, CT, or Tc99CImaging, such as severe claustrophobia

Participants who are pregnant, breastfeeding or have a positive pregnancy test at initial screening visit

Participant is unable to perform spirometry or plethysmography maneuvers

Trial design

Treatments tested in this trial

  • Hyperpolarized 129Xe MRI
  • Tc-99m Technegas Ventilation Imaging

Treatment groups

40 Participants
are divided into 1 treatment group

Sponsors and collaborators

Dr. Grace Parraga

Lead sponsor

Western University, Canada

Sponsor institution

Cyclomedica Australia PTY Limited

Collaborator